Conclusions: Hypoxic condition due to enlarged cell with vascular rarefaction is evident in the proximal tubular area of obese mice whereas tissue reaction to hypoxic damages failed to properly compensate. The early reduction of PHD2 specifi cally in the proximal areamay constitute a novel strategy againstthe progression process from an early stage of obesity-induced kidney injury. Results: Ang II increased mean arterial pressure (MAP) measured by radio-telemetry in cPLA 2 a +/+ but not cPLA 2 a −/− mice (100 ± 2 to 161 ± 6 mmHg vs. 104 ± 3 to 112 ± 3 mmHg, respectively, P < 0.05). Ang II increased cPLA 2 activity, measured by immunohistochemistry using anti-phospho-Ser505, in SFO of cPLA 2 a +/+ but not cPLA 2 a −/− mice. Ang II increased reactive oxygen species (ROS) production measured by dihydroethidium staining (5.09 ± 0.31 to 8.99 ± 0.33 AU, P < 0.05), in SFO of cPLA 2 a +/+ but not in cPLA 2 a −/− mice. Ad-ECFP-cPLA 2 a DNA (1x10 12 pfu/0.5 μL) but not Ad-GFP DNA transduced in SFO of cPLA 2 a −/− mice, restored Ang II effect on MAP and ROS production (115 ± 4 to 149 ± 2 mmHg and 4.40 ± 0.31 to 7.66 ± 0.47 AU with Ad-ECFP-cPLA 2 a DNA vs. 109 ± 5 to 116 ± 4 mmHg, and 4.04 ± 0.35 to 4.56 ± 0.19 AU with Ad-GFP, respectively, P < 0.05). In contrast, Ad-cPLA 2 a shRNA, but not Ad-shRNA transduced in SFO of cPLA 2 a +/+ mice, inhibited cPLA 2 expression and its activity, and abolished Ang II-induced increase in blood pressure.
Results: CM signifi cantly increased urine volume in about two fold throughout the experimental period independently of sodium and osmolyte excretion, indicating that CM increased osmotic free water excretion. The levels of vasopressin, potassium and calcium in blood as well as osmolality in the inner medulla, that is important for urine concentration, were not changed by CM. CM increased mRNA expression of aquaporins and urea transporter, indicating the compensatory induction of these molecules against water loss. Serine protease-specifi c zymography demonstrated that the activities of SPs in urine were substantially changed by CM. Results: AT 1a KO exhibited increased appearance of multilocular lipid droplet and upregulation of thermogenic gene expressions in inguinal white adipose tissues (iWATs) compared to wild-type (WT) mice. AT 2 KO did not show miniaturization of lipid droplet and alteration of thermogenic gene expression levels in iWAT. In vitro experiment using ASCs showed that the deletion of AT 1a receptor resulted in suppression of adipocyte differentiation with reduction in expression of thermogenic genes.
Conclusions

Conclusions:
These results indicate that deletion of AT 1a receptor might have some effects on the process of increasing browning of WAT and indicate that blockade of AT 1 receptor could be a therapeutic target for the treatment of metabolic disorders. Objective: Reports showed that use of combined oral contraceptive (OC) induces hypertension and has been linked with hypertensive complications. Tobacco smoking has also been shown to cause increased risk of developing cardiovascular diseases (CVD) in premenopausal women. Studies also suggest that nicotine, a major tobacco alkaloid may worsen or improve atherothrombotic CVD. Altered hemorheology, prothrombotic and proinfl ammatory markers, have been implicated in the development of atherothrombotic CVD. However, the effect of nicotine exposure on hemorheological, prothrombotic and proinfl ammatory markers during OC treatment is not yet established. We therefore sought to determine the effects of nicotine exposure during OC treatment on hemorheological, prothrombotic and proinfl ammatory markers.
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